News & Updates

$Three anticonvulsive drugs similarly effective in refractory convulsive status epilepticus$

Three anticonvulsive drugs similarly effective in refractory convulsive status epilepticus

20 Jan 2020

The anticonvulsant drugs levetiracetam, fosphenytoin and valproate all demonstrate efficacy for benzodiazepine-refractory convulsive status epilepticus, with each drug inducing seizure cessation and improving alertness in most patients and yielding similar safety outcomes, according to data from the Established Status Epilepticus Treatment Trial (ESETT).

Three anticonvulsive drugs similarly effective in refractory convulsive status epilepticus

20 Jan 2020

Office, workshop workers at high risk for vitamin D deficiency

20 Jan 2020 by

Office and workshop workers were at a greater risk for vitamin D deficiency compared with control room workers, according to a recent Singapore study.

Office, workshop workers at high risk for vitamin D deficiency

20 Jan 2020

Adding metformin to TKI may be detrimental to nondiabetic patients with EGFR-positive NSCLC

19 Jan 2020

The concurrent use of metformin with the tyrosine kinase inhibitor (TKI) gefitinib does more harm than good, resulting in significantly worse outcomes and increasing the risk of diarrhoea in nondiabetic patients with nonsmall cell lung cancer (NSCLC) harbouring EFGR mutation, according to data from a phase II trial.

Adding metformin to TKI may be detrimental to nondiabetic patients with EGFR-positive NSCLC

19 Jan 2020

News & Updates

Filter by Specialty:

Specialty:

Three anticonvulsive drugs similarly effective in refractory convulsive status epilepticus

Three anticonvulsive drugs similarly effective in refractory convulsive status epilepticus

Office, workshop workers at high risk for vitamin D deficiency

Office, workshop workers at high risk for vitamin D deficiency

Adding metformin to TKI may be detrimental to nondiabetic patients with EGFR-positive NSCLC

Adding metformin to TKI may be detrimental to nondiabetic patients with EGFR-positive NSCLC